Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.25 and traded as high as $0.61. Mesoblast shares last traded at $0.61, with a volume of 1,000 shares changing hands.
Mesoblast Trading Up 0.8 %
The company has a fifty day moving average of $0.33 and a two-hundred day moving average of $0.25.
About Mesoblast
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.
Featured Stories
- Five stocks we like better than Mesoblast
- How to Effectively Use the MarketBeat Ratings Screener
- Charles Schwab Fortifies its Uptrend on EPS Beat
- What are earnings reports?
- Lockheed Martin Stock Aims for a Fresh All-Time High
- What Are Dividend Champions? How to Invest in the Champions
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.
